Recruiting
Phase 1
Phase 2

Combination Adjunctive Therapy to Address Multiple Metabolic Imbalances in Type 1 Diabetes

Sponsor:

UCLA

Code:

NCT05696366

Conditions

Type 1 Diabetes

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Sotagliflozin

Volagidemab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information